Frontiers Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study
Frontiers Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease
Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
Frontiers Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer
Frontiers Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis, Cancer Cell International
Cancers, Free Full-Text
Flowchart describing the inclusion and exclusion criteria of patients